{name}
{subtitle}
Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)
city
~12 mi. (Halle (Saale), Germany, +140 more cities)
facility
Universitaetsklinikum Halle ( Site 0213)
drug
lenvatinib, +2 more drugs
drug type
chemotherapy, +2 more types
A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment
city
~12 mi. (Halle (Saale), Germany, +142 more cities)
facility
Universitaetsklinik und Polikl
biomarker
del(11)(q10), +27 more biomarkers
drug
imetelstat, +1 more drug
A Study of Gilteritinib (ASP2215) Combined With Chemotherapy in Children, Adolescents and Young Adults With FMS-like Tyrosine Kinase 3 (FLT3)/Internal Tandem Duplication (ITD) Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
city
~12 mi. (Halle (Saale), Germany, +16 more cities)
facility
Site DE49001
drug
cytarabine, +3 more drugs
drug type
chemotherapy, +2 more types
A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer
city
~30 mi. (Dessau, Germany, +144 more cities)
facility
GSK Investigational Site
drug
carboplatin, +3 more drugs
drug type
chemotherapy, +2 more types
Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047)
city
~37 mi. (Leipzig, Germany, +147 more cities)
facility
Universitaetsklinik Leipzig ( Site 0456)
condition
Cervical Adenocarcinoma, +2 more conditions
drug
brachytherapy, +3 more drugs
drug type
chemotherapy, +2 more types
A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (LEAP-010) (MK-7902-010)
city
~37 mi. (Leipzig, Germany, +127 more cities)
facility
Universitätsklinikum Leipzig-Department for ENT ( Site 2106)
drug
lenvatinib, +1 more drug
drug type
immunotherapy, +1 more type
Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome
city
~37 mi. (Leipzig, Germany, +201 more cities)
facility
Universitaetsklinikum Leipzig /ID# 221168
drug
azacitidine, +1 more drug